Clinical trial
To Study the Efficacy and Safety of Furocyst in Poly Cystic Ovary Syndrome Patients (PCOS)
NCT02703064 is registered in ClinicalTrials.gov with Chemical Resources as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Study the Efficacy and Safety of Furocyst in Poly Cystic Ovary Syndrome Patients (PCOS)
- Lead sponsor
- Chemical Resources
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 26, 2015
- Completion date
- July 31, 2017
- Enrollment
- 107 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pcos